Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Gynecology

Symptoms, Diagnosis, and Your Pathology Report

At a Glance

Vulvar Intraepithelial Neoplasia (VIN) often causes intense itching and visible skin changes, and is diagnosed via biopsy. Your pathology report must specify if you have HPV-associated vHSIL or HPV-independent dVIN, confirmed by p16 or p53 markers, to guide the correct treatment plan.

Navigating the diagnosis of Vulvar Intraepithelial Neoplasia (VIN) involves a specific set of steps and a very detailed laboratory report. Understanding what your doctor is looking for—and what your report should contain—can help you feel more in control of your care.

Common Symptoms

Many women with VIN have no symptoms at all, and the condition is only found during a routine physical exam. However, when symptoms do occur, they often include:

  • Intense Itching (Pruritus): This is the most common symptom and can sometimes be mistaken for a chronic yeast infection or general irritation [1].
  • Visible Skin Changes: The area may look different from the surrounding skin. These patches can be white, gray, red, or dark brown. They may be flat or slightly raised (like a small bump or wart) [2].
  • Pain or Burning: Some women experience localized soreness or a burning sensation, especially during activities like exercise or sexual intercourse.

The Diagnostic Process

If your doctor suspects VIN, they will perform two main diagnostic steps:

  1. Vulvoscopy: Similar to a colposcopy used for the cervix, the doctor uses a specialized magnifying lens (a vulvoscope) to look closely at the vulvar skin. They may apply a mild vinegar-like solution (acetic acid) to the skin, which helps abnormal areas stand out by turning them white.
  2. Biopsy: To confirm a diagnosis, a small sample of skin must be removed and sent to a lab. This is usually a “punch biopsy,” where a small tool (about the size of a pencil eraser) takes a circular sample after the area has been numbed with a local anesthetic.

Reading Your Pathology Report

Your pathology report is the “blueprint” for your treatment. A complete report should provide more than just a name; it should give your care team specific details about the biology of the cells.

The Completeness Checklist

Ensure your report includes these three critical pieces of information:

  • The Specific Subtype: It should clearly state if the lesion is vHSIL (HPV-associated) or dVIN (HPV-independent) [3][4].
  • Immunohistochemistry (IHC) Markers: These are “stains” used to confirm the diagnosis.
    • p16: If this is “block-positive,” it strongly suggests an HPV-associated lesion (vHSIL) [5].
    • p53: If this shows a “mutant” pattern (either too much or none at all), it is a hallmark sign of the more aggressive dVIN [6][7].
    • Other Markers: You may also see terms like CK17, SOX2, or GATA3. These are newer tools pathologists use to help confirm dVIN, especially when the results for p53 are unclear [8][9].
  • Margin Status (for excisions): If your doctor removed the entire area of concern (an excision), the report will mention margins.
    • Negative/Clear Margins: This means the pathologist found healthy tissue at the very edge of the sample, suggesting the entire lesion was removed [10]. In the case of dVIN, achieving wide, clear margins is an absolute requirement [11].
    • Positive/Involved Margins: This means abnormal cells were found right at the edge, indicating that some abnormal cells may still remain in the body, which increases the risk of the condition coming back [12][13]. Note: For HPV-associated vHSIL, surgeons sometimes intentionally accept close or slightly positive margins in order to preserve healthy tissue, sexual function, and normal anatomy. In these cases, close surveillance is used to manage any remaining cells [14].

If your report is missing these details, it is appropriate to ask your doctor if “supplemental stains” like p16 or p53 were performed or if they can be ordered to ensure the diagnosis is as accurate as possible [15].

Return to Home Page

Common questions in this guide

What are the most common symptoms of VIN?
Many women with Vulvar Intraepithelial Neoplasia have no symptoms. When symptoms do occur, the most common is intense itching, which can sometimes be mistaken for a yeast infection. You might also notice visible skin changes like white, gray, red, or dark brown patches, or experience pain and burning.
How is Vulvar Intraepithelial Neoplasia diagnosed?
Diagnosis usually involves a vulvoscopy, where a doctor uses a specialized magnifying lens to examine the vulvar skin closely. If they spot abnormal areas, they will perform a punch biopsy to remove a small tissue sample for laboratory testing.
What is the difference between vHSIL and dVIN on a pathology report?
These are the two main subtypes of the condition. vHSIL is associated with the human papillomavirus (HPV) and is often confirmed using a p16 stain. dVIN is HPV-independent, tends to be more aggressive, and is typically identified by an abnormal p53 stain.
What does it mean if my VIN excision margins are positive?
Positive or involved margins mean abnormal cells were found at the very edge of the removed tissue, suggesting some abnormal cells may remain. For dVIN, doctors usually require clear margins, but for vHSIL, close margins are sometimes accepted to preserve normal anatomy and sexual function.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my pathology report clearly state whether this is vHSIL (HPV-associated) or dVIN (HPV-independent)?
  2. 2.Was the 'p53' staining pattern normal ('wild-type') or abnormal ('mutant')?
  3. 3.Were my surgical margins 'clear' or 'negative,' and if so, what was the distance to the edge?
  4. 4.If my biopsy didn't use p16 or p53, would you recommend re-evaluating the tissue with those markers to confirm the subtype?
  5. 5.Given the symptoms I've had, like intense itching, do you see any signs of other skin conditions like lichen sclerosus on my exam?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    2016 European guideline for the management of vulval conditions.

    van der Meijden WI, Boffa MJ, Ter Harmsel WA, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(6)):925-941 doi:10.1111/jdv.14096.

    PMID: 28164373
  2. 2

    The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions.

    Pagan L, Huisman BW, van der Wurff M, et al.

    Frontiers in microbiology 2023; (14()):1264768 doi:10.3389/fmicb.2023.1264768.

    PMID: 38094635
  3. 3

    Precancerous Squamous Lesions of the Vulva.

    Welch KC, Haefner HK, Saunders NA

    Obstetrics and gynecology 2025; doi:10.1097/AOG.0000000000006150.

    PMID: 41380160
  4. 4

    p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.

    Woelber L, Prieske K, Eulenburg C, et al.

    American journal of obstetrics and gynecology 2021; (224(6)):595.e1-595.e11 doi:10.1016/j.ajog.2020.12.1220.

    PMID: 33453182
  5. 5

    Typing of Vulvar Squamous Cell Carcinoma: Why it is Important?

    Alfaraidi M, Gilks CB, Hoang L

    Advances in anatomic pathology 2025; (32(1)):20-29 doi:10.1097/PAP.0000000000000466.

    PMID: 39318249
  6. 6

    Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva.

    Liu YA, Ji JX, Almadani N, et al.

    Histopathology 2021; (78(3)):424-433 doi:10.1111/his.14238.

    PMID: 32799363
  7. 7

    Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.

    Tessier-Cloutier B, Pors J, Thompson E, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021; (34(2)):508-518 doi:10.1038/s41379-020-00651-3.

    PMID: 32792599
  8. 8

    Expression of CK17 and SOX2 in Vulvar Intraepithelial Neoplasia: A Comprehensive Analysis of 150 Vulvar Lesions.

    Thuijs NB, Voss FO, Ewing-Graham PC, et al.

    Cancers 2024; (16(23)) doi:10.3390/cancers16233966.

    PMID: 39682153
  9. 9

    GATA3 immunohistochemistry as a diagnostic adjunct for differentiated vulvar intraepithelial neoplasia: utility and limitations.

    Zare SY, Fard EV, Fadare O

    Human pathology 2023; (139()):55-64 doi:10.1016/j.humpath.2023.07.005.

    PMID: 37454993
  10. 10

    Incidence and Risk Factors for Recurrence and Progression of HPV-Independent Vulvar Intraepithelial Neoplasia.

    Voss FO, van Beurden M, Veelders KJ, et al.

    Journal of lower genital tract disease 2024; (28(2)):153-159 doi:10.1097/LGT.0000000000000794.

    PMID: 38518213
  11. 11

    The Vulvar Cancer Risk in Differentiated Vulvar Intraepithelial Neoplasia: A Systematic Review.

    Voss FO, Thuijs NB, Vermeulen RFM, et al.

    Cancers 2021; (13(24)) doi:10.3390/cancers13246170.

    PMID: 34944788
  12. 12

    Vulvar intraepithelial neoplasia: Risk factors for recurrence.

    Satmary W, Holschneider CH, Brunette LL, Natarajan S

    Gynecologic oncology 2018; (148(1)):126-131 doi:10.1016/j.ygyno.2017.10.029.

    PMID: 29126556
  13. 13

    Vulval Intraepithelial Neoplasia: A 15-Year Review of Treatment Outcomes in a UK Centre.

    McGowan MA, Haldar K, Pathiraja P, et al.

    Cureus 2025; (17(10)):e95074 doi:10.7759/cureus.95074.

    PMID: 41280995
  14. 14

    Combination of surgery and laser for the treatment of extensive VIN3 and vulval condyloma: A case report.

    Farzaneh F, Khalili L, Rakhshani N, et al.

    Annals of medicine and surgery (2012) 2022; (78()):103763 doi:10.1016/j.amsu.2022.103763.

    PMID: 35734690
  15. 15

    Role of Immunohistochemical Analysis of p16 and p53 in Vulvar Carcinoma.

    Choschzick M, Gut A, Hoesli L, Stergiou C

    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2025; (44(4)):308-313 doi:10.1097/PGP.0000000000001077.

    PMID: 39480105

This page explains Vulvar Intraepithelial Neoplasia (VIN) symptoms and pathology terminology for educational purposes. Always consult your gynecologist or oncologist for an accurate diagnosis and help interpreting your specific biopsy results.

Get notified when new evidence is published on Vulvar intraepithelial neoplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.